These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32327362)

  • 1. DAAs and HBV/HCV coinfection: Glimmer of light and a few shades of grey.
    Roy A; De A; Singh V
    J Hepatol; 2020 Aug; 73(2):461. PubMed ID: 32327362
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "DAA and HBV/HCV co-infection: Glimmer of light and a few shades of grey".
    Yeh ML; Yu ML
    J Hepatol; 2020 Aug; 73(2):462. PubMed ID: 32327360
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.
    Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V
    J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism and clinical significance of HBV reactivation after anti-HCV therapy].
    Zeng WJ; Gao L; Xu YW; Chen XM; Wang FS; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):997-1001. PubMed ID: 36299197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.
    Butt AA; Yan P; Aslam S; Abou-Samra AB; Sherman KE; Shaikh OS
    Clin Infect Dis; 2020 Jul; 71(3):664-666. PubMed ID: 31840746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection.
    Jacob R; Danta M
    Expert Opin Pharmacother; 2022 Mar; 23(4):465-472. PubMed ID: 34937470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.
    Butt AA; Yan P; Aslam S; Sherman KE; Siraj D; Safdar N; Hameed B
    Int J Infect Dis; 2020 Mar; 92():184-188. PubMed ID: 31978574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus and coinfection with hepatitis B and C.
    Petty LA; Steinbeck JL; Pursell K; Jensen DM
    Infect Dis Clin North Am; 2014 Sep; 28(3):477-99. PubMed ID: 25151567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
    Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.
    Butt AA; Yan P; Shaikh OS; Abou-Samra AB
    Aliment Pharmacol Ther; 2018 Feb; 47(3):412-420. PubMed ID: 29181838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
    De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
    J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.
    Stroffolini T; Sagnelli E; Sagnelli C; Smedile A; Furlan C; Morisco F; Coppola N; Andriulli A; Almasio PL
    Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial Commentary: Another Call to Cure Hepatitis B.
    Balagopal A; Thio CL
    Clin Infect Dis; 2015 Oct; 61(8):1307-9. PubMed ID: 26082512
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
    Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
    Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
    Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C virus infection and risk of haematological malignancies.
    Marrone A; Ciotti M; Rinaldi L; Adinolfi LE; Ghany M
    J Viral Hepat; 2020 Jan; 27(1):4-12. PubMed ID: 31325404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
    Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
    Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.
    Collins JM; Raphael KL; Terry C; Cartwright EJ; Pillai A; Anania FA; Farley MM
    Clin Infect Dis; 2015 Oct; 61(8):1304-6. PubMed ID: 26082511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus and Hepatitis B Virus Co-Infection.
    Shih YF; Liu CJ
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.